Your Mounjaro price guide · October 2026
Does GLP-1 Reduce Libido? What UK Patients Should Know (October 2026)
Reduced libido is not a listed side effect of Mounjaro (tirzepatide) in the UK patient leaflet.1 Some people do notice a change in desire during treatment, and many other factors can explain it. If it bothers you, tell your prescriber.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Compare UK Mounjaro Prices
Prices checked 11 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Reduced libido is not a listed side effect in the Mounjaro SmPC or patient leaflet.
-
A change in desire during treatment has many possible causes, so timing alone does not prove the medicine is responsible.
-
Do not stop treatment on your own. Talk to your prescriber or GP, and report new symptoms through the Yellow Card scheme.
-
Oral contraceptives may be absorbed less well because stomach emptying slows: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after starting and for 4 weeks after each dose increase.
In this guide
01 · The short version
Is low libido a known effect of GLP-1 medicines?
Low libido is not a listed side effect of Mounjaro in the UK Summary of Product Characteristics or the patient information leaflet.113
This does not mean your experience is imaginary. Libido is shaped by sleep, stress, mood, relationships, other medicines, health conditions and life stage. Starting a weight-loss treatment is often a period of big change in eating, routine and body image, and any of those can shift desire.
02 · What to do
Is this relevant to you, and what should you do next?
It is relevant if you have noticed a clear change since starting treatment, or if you are worried before starting. The sensible next step is to note when the change began, what else changed around then, and whether it is steady or comes and goes. That gives your prescriber something concrete to work with.
If you are already a customer, raise it at your monthly review. Our prescribing team offers ongoing reviews and side-effect support, and a symptom that is not on the label still deserves a proper conversation. If you are not a customer, your GP can look at the wider picture, including hormones, mood and other medicines.
Please do not stop or change your dose without advice. Stopping does not give a quick answer either, because tirzepatide takes roughly four to five weeks to clear the system after a final dose, and nothing speeds that up.1 Report any new symptom through the Yellow Card scheme, which helps regulators spot patterns over time.19
We have separate guides on libido on Mounjaro specifically and how women may experience it.
03 · Weighing it up
How to tell whether the medicine is the likely cause
Timing is the first clue, but it is a weak one on its own. A change that begins in the same week as a dose increase is worth noting. A change that crept in over months alongside poor sleep or a stressful period points elsewhere. Neither pattern is proof.
| What you notice | What it might suggest | Useful next step |
|---|---|---|
| Desire dips for a day or two after your injection | Possibly linked to how you feel on injection days, such as tiredness or an unsettled stomach | Keep a short note and share it at your review |
| Desire has faded gradually alongside low mood or stress | Mood and stress commonly affect libido regardless of medicines | Speak to your GP about mood and wellbeing |
| Desire changed around the time another medicine was started | Other medicines may be involved | Ask your pharmacist or GP to review all your medicines |
| Desire is low alongside other new physical symptoms | Needs a proper medical assessment | Book a GP appointment and tell your prescriber |
| No change at all | Consistent with the product information | Carry on as advised |
The table is a thinking aid, not a diagnosis. Only a clinician who knows your history can sort out the cause.
04 · What the label says
What the product information says about libido
The UK product information for Mounjaro does not list reduced libido as a side effect. The Summary of Product Characteristics is the document prescribers rely on, and the patient information leaflet is the plain-English version that comes in the box.113 Neither names loss of sexual desire as an effect of tirzepatide.
That matters because these documents are built from clinical trials and from safety monitoring after a medicine is on the market. If a pattern were established, it would be added. The absence of an entry is not the same as proof that no individual could ever be affected. It means that the effect is not established.
The honest position is in between: not a recognised effect, and still worth discussing if you notice it.
Why individual reports do not settle it
Online forums are full of personal stories, some saying desire fell and others saying it rose. People who start a weight-loss medicine are also changing food, activity, sleep and often their whole routine. Any single story mixes the medicine with everything else going on.
How to report a new symptom
If you notice something that is not in the leaflet, tell your prescriber and consider reporting it through the MHRA Yellow Card scheme.19 Anyone can report, including patients. Reports are pooled and reviewed by the regulator, which is how genuine new signals get identified. A report from you does not mean you are blaming the medicine. It simply adds a data point.
When you report or raise it with a clinician, say what changed, roughly when, whether it is constant or variable, and which other medicines you take. Specific detail is far more useful than a general worry. Our wider guide to GLP-1 treatment and libido explains how to frame that conversation.
Finally, remember that the leaflet covers what is known today. Safety information is updated as evidence grows, so check the current leaflet that comes with your pen.
05 · How the medicine works
How tirzepatide works, and why that is not the same as a libido effect
Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.1 In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.
That description covers appetite, digestion and blood-sugar handling. It does not describe an action on sexual desire. Some websites claim otherwise, but this is not established.
Why people wonder about it anyway
The question is natural. If a medicine quietens the urge to eat, it is reasonable to ask whether it quietens other urges. Appetite and desire both involve the brain and hormones, so the idea feels plausible. Plausible is not the same as established, though, and the label does not list the effect.
It also helps to separate two things. Feeling less interested in food is the intended result of treatment. Feeling less interested in sex is not a result the product information describes. If both happen together, they might be connected, or they might simply be happening at the same time.
What the medicine is licensed for
Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes.1 It is used alongside a reduced-calorie diet and increased physical activity. Those lifestyle changes are part of the treatment, and they are also a source of the big routine shifts that can influence how you feel day to day.
Single-action and dual-action medicines
Tirzepatide's dual action sets it apart from single-action GLP-1 medicines such as semaglutide. If you want to compare the two for weight management, our Wegovy pen page and the Mounjaro page set out the details.
The practical takeaway: understanding the mechanism does not hand you a libido answer. Treat any claim of a precise brain-reward explanation as unconfirmed, and focus on what you can observe and discuss with a clinician.
06 · Overlapping factors
Everyday factors that can lower desire during weight loss
Several ordinary factors can reduce libido at any time, and they often coincide with starting a weight-loss treatment. Sorting through them is usually more productive than asking whether one medicine is to blame.
Energy and routine
Eating less, changing meal patterns and becoming more active can all leave you feeling different from usual. Tiredness is one of the most common reasons anyone feels less interested in sex. If you are running on low energy because you are adjusting to a new routine, desire can understandably take a back seat. Talk to your prescriber if tiredness is a persistent problem, because that is worth looking at in its own right.
Digestive comfort
When your stomach feels unsettled, intimacy is rarely the first thing on your mind. This applies to any cause of digestive discomfort. If you are having digestive symptoms that interfere with daily life, tell the prescribing team, who provide side-effect support and can advise on what to do.
Mood, stress and sleep
Mood and stress are among the best-recognised influences on libido. Many people begin treatment at a point of high stress about health or body image, or after a difficult period. Poor sleep adds to that. If your mood has dipped, please speak to your GP. Mood changes deserve attention regardless of cause, and you should never feel you have to cope alone.
Relationships and body image
Desire is not purely physical. Changes to how you see your body, how your partner reacts, or how your routines fit together can all play a part. Some people feel more confident as their body changes. Others feel self-conscious while the change is under way. Both are normal, and neither tells you anything about the medicine.
Other medicines and health conditions
Many people who use weight-management treatment also take other medicines or live with conditions such as type 2 diabetes, which can themselves affect sexual function. If your libido shifted when something else changed, mention that to your GP or pharmacist. A full medicines review can untangle what is doing what.
Life stage and hormones
Natural hormonal changes, including those linked to the menopause transition in women, can affect desire. Our guide on libido and Mounjaro in women covers this in more depth. If you suspect a hormonal cause, a GP can arrange appropriate checks.
None of this rules the medicine in or out. It simply shows how many candidates there are, which is why careful observation and a conversation with a clinician beat guessing.
07 · Hormones and contraception
Does GLP-1 treatment mess with your hormones?
GLP-1 and GIP medicines act on gut-hormone receptors that regulate appetite, stomach emptying and insulin response.1 That is a different system from the sex hormones that govern reproduction and, in part, desire. The product information does not list an effect on sex hormones or libido, so it would be wrong to say the medicine disrupts them.
It is true that weight change itself can interact with the body's hormonal balance in some people. If you have symptoms that suggest a hormonal problem, such as changes to your cycle, a GP can arrange sensible tests.
The contraception point that does matter
One hormone-related issue is well established. Mounjaro can reduce the absorption of oral contraceptives because it slows how quickly the stomach empties.7 The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.1 That is relevant to anyone for whom a pregnancy would be unwelcome, because a contraceptive that is absorbed less well may protect less well.
If you use an oral contraceptive, speak to your prescriber or pharmacist about the best way to stay protected while you are on treatment. Do not assume your usual pill is enough. This is practical advice that has nothing to do with libido, but it often comes up in the same conversation, so it is worth knowing.
Who this affects
The MHRA has published guidance on contraception with GLP-1 and GIP medicines.7 If you could become pregnant, check the current guidance with your prescriber before you start and whenever your dose changes. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.
Talking about intimacy and sexual health
Clinicians are used to questions about desire, arousal and sexual function. Raising them is not embarrassing for them, and it helps them give better advice. Whatever the cause, being specific about what you are experiencing makes the conversation quicker and more useful.
In short, the medicine acts on appetite and metabolism hormones, the label does not list a libido or sex-hormone effect, and the one hormone-related thing to act on is contraception.
08 · After stopping
Does libido return after stopping a GLP-1 medicine?
If your libido has changed and the medicine is part of the cause, it may improve after treatment ends.
Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.1 Any change that is directly tied to the medicine would not be expected to resolve instantly, so give things time before drawing conclusions.
Do not stop on a hunch
Stopping a weight-management treatment because of a change that may not even be caused by it can mean giving up benefits for nothing. If libido is a concern, discuss it first. Your prescriber can review your dose, your wider health and your other medicines, and can help you decide whether a change makes sense. Our monthly reviews exist for exactly this kind of question.
If it does not return
If desire stays low weeks after the medicine has cleared, that points strongly to another cause. Mood, stress, sleep, relationships, other medicines, hormonal changes and underlying health conditions are all worth checking. A GP appointment is the right next step, and it is better to book one sooner than to wait months hoping it resolves.
Restarting or changing doses
Do not change your dose or schedule yourself. Any change to your treatment should go through the prescribing team. If you are thinking about a break, ask what it would mean for your plan before you do anything. Our consultation is free.
Stopping and weight regain
Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. If you are weighing up stopping, ask about how to maintain what you have achieved. The decision is yours, and it is best made with a clinician who knows your history.
09 · Practical steps
How to improve libido while on treatment
There is no clinical treatment for libido to recommend here, and supplements or quick fixes are best avoided. What we can offer are sensible, low-risk steps that put you in a better position to work out what is going on.
Start with observation
Keep a simple note for a few weeks. Record your injection day, your mood, your sleep, how your stomach feels and how interested you are in intimacy. Patterns often become visible quickly. You can take that note to your prescriber or GP, which makes the appointment much more productive. Our free GLPTrackr companion app can help you keep a record of your treatment journey.
Look after the basics
Sleep, stress and mood influence desire more than most people expect. Treat them as part of your plan, not as extras. Follow the diet and activity advice your prescriber has agreed with you, because treatment is meant to work alongside it, and keep regular meals and routines where you can.
Talk to your partner
Desire often responds to feeling close and relaxed, and pressure tends to make things harder. An honest conversation about what is changing, and why you are not sure, can reduce pressure on both sides. It also helps if your partner understands you are looking into it rather than withdrawing.
Ask for a medicines review
If you take other medicines, ask your pharmacist or GP whether any could affect desire. Do not stop any of them on your own. A review is quick and often reassuring.
Speak to your prescriber about your treatment
Raise the change at your review. Prescribers can look at your dose and how you are doing overall.
Get checked if it persists
If low desire continues, or comes with other symptoms such as persistent low mood, ongoing tiredness or changes to your cycle, see your GP. They can arrange tests and discuss support options. Because we are a full online pharmacy, we can also point you to sexual health services if that is the right route.
What we would avoid: unregulated products promising to boost libido, and anyone offering medicines without a consultation or prescription. These carry real risks, and they do not address the underlying cause. Our guide on Mounjaro and anxiety may also be useful if mood is part of your picture.
10 · Weight loss and desire
Is low libido normal while losing weight?
A change in desire during weight loss is common enough to be worth talking about, and it does not always involve a medicine. Large changes to eating, activity, body shape and daily rhythm touch many parts of life, so it is reasonable for sexual interest to shift too, in either direction.
The trial evidence for Mounjaro is about weight, not libido. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2 These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.
Quick change and how it feels
People who lose weight steadily often say they feel more confident and energetic. Others find the process unsettling, because their body and habits feel unfamiliar. Neither reaction is a verdict on the treatment. What matters is how you are doing overall, and whether you can talk about it.
Setting expectations
Starting treatment is not a promise of any particular change in your wellbeing, positive or negative. A fair expectation is that you will lose weight at a pace that varies from person to person, that you may notice shifts in appetite and digestion, and that other areas of life may change as you adapt. If one of them worries you, you are encouraged to raise it.
Other questions people ask
If you are considering any unlicensed product, speak to a clinician first, and be wary of anyone selling it without a prescription.
You may also be wondering about age. Libido varies widely between people and across life stages, and there is no single age at which it drops. Rather than looking for a number, look at your own pattern and discuss it with a clinician if it concerns you.
11 · Getting support from us
Getting support, and how treatment works with us
If you are already on treatment with us, ongoing monthly reviews, dose-titration and follow-up assessments by our prescribing team are part of the service, along with side-effect support. That is the right place to raise a change in desire. You do not need to have a definite cause in mind. A description of what you have noticed is enough to start.
If you are considering treatment, here is how it works. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber.
- Free online consultation: a short health questionnaire, no charge and no obligation.
- Prescriber review: reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
- Dispensing and dispatch: dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm.
- Delivery: free next-day tracked delivery in discreet, temperature-controlled packaging. Saturday delivery is £14.99.
We supply genuine Mounjaro KwikPens through official LillyDirect supply, direct from Eli Lilly's UK distribution. All six doses are in stock. Needles, a sharps bin and injection guidance come with every order.
NHS or private?
Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).46 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.
Mounjaro is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice. Our support team is available Monday to Friday, 9am to 5pm, on 0333 207 0413 or at support@everydaymeds.co.uk. We are registered with the GPhC under number 9012878.
If you are curious about the wider biology of these medicines, our guide on why GLP-1 medicines may affect inflammation is a good next read.
12 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamDoes GLP-1 reduce libido?
How can I increase libido while on GLP-1 treatment?
Does libido return after stopping a GLP-1 medicine?
Does GLP-1 mess with your hormones?
Is it normal to have low libido while losing weight?
What decreases libido the most?
At what age does women's libido drop?
How do I turn my libido back on?
Should I stop Mounjaro if my libido drops?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 8 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- BNF — Tirzepatide: indications, dosing and safety information
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- MHRA Yellow Card scheme — report a side effect
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


